BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23382603)

  • 21. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases.
    Hoyer JD; Ross CW; Li CY; Witzig TE; Gascoyne RD; Dewald GW; Hanson CA
    Blood; 1995 Aug; 86(3):1163-9. PubMed ID: 7620169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B- and T-cell prolymphocytic leukemia: antibody approaches.
    Dearden C
    Hematology Am Soc Hematol Educ Program; 2012; 2012():645-51. PubMed ID: 23233647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolymphocytic leukemia: clinical, histopathological, and cytochemical observations.
    Bearman RM; Pangalis GA; Rappaport H
    Cancer; 1978 Nov; 42(5):2360-72. PubMed ID: 719613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy.
    Sakhdari A; Tang G; Ginsberg LE; Hirsch-Ginsberg CF; Bueso-Ramos CE; Medeiros LJ; Miranda RN
    Case Rep Pathol; 2019; 2019():4915086. PubMed ID: 30941227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B and T cell prolymphocytic leukaemia.
    Cross M; Dearden C
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
    Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
    Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and Immunophenotypic Properties of Small Cell Variant of T-cell Prolymphocytic Leukemia].
    Yu YP; Wang LP; Song P; Mei JG; An ZM; Zhou XG; Li F; Tang YM; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):8-15. PubMed ID: 28245368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolymphocytic leukemia.
    Stone RM
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell prolymphocytic leukemia: an enduring bona fide entity.
    Gonzalez-Mancera MS; Lopategui J; Hoffman D; Kitahara S; Alkan S
    Int J Hematol; 2024 May; ():. PubMed ID: 38796826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
    Hu Z; Li S; Medeiros LJ; Sun T
    Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic considerations in prolymphocytes in pleural fluid: a case report.
    Anand M; Sharma S; Kumar R; Raina V
    Acta Cytol; 2008; 52(2):251-4. PubMed ID: 18500006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell prolymphocytic leukemia. Clinical and immunologic characterization.
    Volk JR; Kjeldsberg CR; Eyre HJ; Marty J
    Cancer; 1983 Dec; 52(11):2049-54. PubMed ID: 6226353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.
    Matutes E; Brito-Babapulle V; Swansbury J; Ellis J; Morilla R; Dearden C; Sempere A; Catovsky D
    Blood; 1991 Dec; 78(12):3269-74. PubMed ID: 1742486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia.
    Heinonen K; Mahlamäki E; Hämäläinen E; Nousiainen T; Mononen I
    Cancer Genet Cytogenet; 1994 Nov; 78(1):28-35. PubMed ID: 7987802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prolymphocytic leukemia: the therapeutic strategy].
    Fava S; De Paoli A; Grimi E; Luoni M; Tocci A; Tosi A; Cassi E
    Recenti Prog Med; 1994 Oct; 85(10):496-501. PubMed ID: 7809465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell Prolymphocytic Leukemia.
    Sud A; Dearden C
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):273-283. PubMed ID: 28340878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
    Guillaume T; Beguin Y; Tabrizi R; Nguyen S; Blaise D; Deconinck E; Redjoul R; Cornillon J; Guillerm G; Contentin N; Sirvent A; Turlure P; Salmon A; Huynh A; François S; Peffault de Latour R; Yakoub-Agha I; Mohty M
    Eur J Haematol; 2015 Mar; 94(3):265-9. PubMed ID: 25130897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia.
    Merdin A; Yıldız J; Dal Mehmet S; Çakar MK; Batgi H; Tekgündüz E; Onursever A; Altuntaş F
    Hematol Rep; 2017 Feb; 9(1):6995. PubMed ID: 28435655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.